ArticleCancers2022

Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis.

Catherine Leyh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.